12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Other News

Alize Pharma, Bertin Technologies S.A.S., Ricerca, French National Institute of Health and Medical Research (Inserm), Lyon School of Veterinary Medicine cardiov

Alize launched the €3.9 million ($5.1 million) PREMAG collaborative research program to develop Alize's AZP-531.The group will develop the unacylated ghrelin analog for indications including cardiovascular complications of diabetes, cardioprotection following ischemia-reperfusion and cachexia...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >